A Phase I Study of the Raf Kinase/Vegf-R Inhibitor Sorafenib in Combination with Bortezomib in Patients with Advanced MalignancyS. Kumar,R. S. Marks,R. Richardson,F. Quevedo,G. A. Croghan,S. N. Markovic,R. Qin,A. D. Tan,J. R. Molina,C. E. Erlichman,A. A. AdjeiJournal of clinical oncology（2008）引用 24|浏览51暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
